Aclarion (ACON) Preferred Stock Liabilities (2021)

Aclarion (ACON) reported Preferred Stock Liabilities of $7.1 million for Q4 2021.

Aclarion (ACON) Preferred Stock Liabilities (2021) Analysis & Trends

Aclarion has reported Preferred Stock Liabilities for 1 years, with the latest figure at $7.1 million in Q4 2021.

  • For the quarter ending Q4 2021, Preferred Stock Liabilities changed N/A year-over-year to $7.1 million; the trailing twelve-month figure through Dec 2021 stood at $7.1 million (changed N/A YoY), and the FY2021 full-year result was $7.1 million, changed N/A from the prior year.
  • Preferred Stock Liabilities for Q4 2021 stood at $7.1 million.
  • The five-year high for Preferred Stock Liabilities was $7.1 million in Q4 2021, with the low at $7.1 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn -
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn -
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn -
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn 199.87 Mn
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn -
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn -
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn -
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn -
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn -
10 Aclarion 6.68 Mn -12.07 Mn 3,750.00 -

Historic Data

Download Data
DateValue
Dec 31, 2021 7.10 Mn